Attachment 1D. |
TB Notification Message |
Mapping Guide 06052007.xls |
TB Notification Message Mapping Guide | ||||||||
VERSION: The version of this Message Mapping Guide is Draft 0.6 dated 6/5/2007. | ||||||||
This Message Mapping Guide describes the content and message mapping specifications for the fixed set of data elements used to communicate information to meet the requirements for TB Individual Case reporting to CDC. The intended audience for this document are the state/local and CDC programs and other public health related organizations interested in using the HL7 V2.5 case notification message specification for transmitting their data elements. | ||||||||
References | ||||||||
Version 1.0 of the Message Specification Guide is used to inform the mapping methodology for this guide. | ||||||||
Notify CDC Message–All PAMs from NEDSS PAM Platform Team. Last updated 1/26/2007. | ||||||||
NEDSS PAM Platform Help Guide, 11/30/2006. | ||||||||
Understanding the Organization of the Mapping Guide | ||||||||
Revisions | This tab is intended to provide revision control for updates made to the document. | |||||||
Key | Key to columns in each Tab/Worksheet | |||||||
Subject-related | This tab provides the mapping methodology for the demographic variables requested by the program. | |||||||
Generic Obs. | This tab provides the content for the generic investigation questions (observations). The ones that are not used for this particular instance are greyed out. | |||||||
TB Observations | This tab provides the investigation/case-related content requested by the program for this specific notification. | |||||||
Notification Structure | This tab provides the structural elements for the Notification. These variables are not negotiable. Default values are provided for HL7 structural elements that are required but not part of the surveillance data requested. | |||||||
Variables as Observations | ||||||||
Other than the variables that map to the Patient Identifier segment (see Subject-Specific tab), all other variables are passed as a series of OBX-Observation/Result segments that are logically tied to the OBR-Observation Request “section header” segment that immediately precedes it. This content presents the real differences between the messages since all types of Notifications are handled in a standard manner up to this point. |
Revisions | ||
Date | Version | Description |
4/20/2007 | Draft v. 0.5 | Added "notification subject type" to the Notification Structural Data to bring the message structure in line with the Outbreak Management version of the ORU Case Investigation Report message. |
4/20/2007 | Draft v. 0.5 | Changed all observations that use the CE value type in OBX-2 to CWE - coded with exception - to prepare for versioning of value sets. The additional fields are still optional at this point. |
4/24/2007 | Draft v. 0.5 | Added "patient name type" to the Notification Structural data to account for the default value that must be provided in the message. |
4/24/2007 | Draft v. 0.5 | Remapped NTF139 to NOT108 for use as the PHIN Variable ID used for MSH-10 Message Control ID (UID nor text appears in this context) |
5/3/2007 | Draft v. 0.5 | Removed NOT110 Record Type variable. This observation is no longer necessary as the Notification Type specified in NOT101 contains this information. |
6/5/2007 | Draft v. 0.6 | Created a Generic Observations tab and greyed out any generic surveillance questions that TB does not use. Only the TB-specific observations remain on the TB Observations tab. |
Key to columns in each Tab/Worksheet: | ||||||||
Column | Description | |||||||
Program Variables Section | ||||||||
PHIN Variable ID | PHIN element UID drawn from the coding system PH_PHINQuestions_CDC | |||||||
Label | Short name for the data element, which is passed in the message. | |||||||
Description | Description of the data element as in PHIN Questions. | |||||||
Data Type | Data type for the variable response expected by the program area | |||||||
Prog. Req/Opt | Indicator whether the program specifies the field as: R - Required - mandatory for sending the message O - Optional - if the data is available it should be passed |
|||||||
Coded Concepts | Concepts that the program uses in answer to a particular question that required a coded response. | |||||||
May Repeat | Indicator whether the response to the data element may repeat. “Yes” in the field indicates that it may; otherwise, the field is not populated. Repeats require special processing. | |||||||
Data Validation | Business rules used for validating data integrity | |||||||
Value Set Name | Name of the pre-coordinated value set from which the response is drawn. The value sets and coding systems are accessible via the Public Health Information Network Vocabulary Access and Distribution Services at http://www.cdc.gov/PhinVSBrowser/StrutsController.do. | |||||||
Message Mapping Methodology Section | ||||||||
Message Context | Specific HL7 segment and field mapping for the element. | |||||||
HL7 Data Type | HL7 data type used by PHIN to express the variable. | |||||||
HL7 Usage | Use of the field for PHIN. Indicates if the field is required, optional, or conditional in a segment. The only values that appear in the Message Mapping are: • R – Required. Must always be populated • O – Optional. May optionally be populated. |
|||||||
HL7 Cardinality | Indicator of the minimum and maximum number of times the element may appear. • [0..0] Element never present. • [0..1] Element may be omitted and it can have at most, one Occurrence. • [1..1] Element must have exactly one Occurrence. • [0..n] Element may be omitted or may repeat up to n times. • [1..n] Element must appear at least once, and may repeat up to n times. • [0..*] Element may be omitted or repeat for an unlimited number of times. • [1..*] Element must appear at least once, and may repeat unlimited number of times. • [m..n] Element must appear at least m, and at most, n times. |
|||||||
Implementation Notes | Related implementation comments. |
Subject/Demographic Variables | Mapping Methodology | |||||||||||||
PHIN Variable ID | Label/Short Name | Description | Data Type | CDC Req/Opt | May Repeat | Coded Concepts | Value Set Name | Data Validation | Message Context | HL7 Data Type | HL7 Usage | HL7 Cardinality | Implementation Notes | |
DEM197 | Local patient ID | The local ID of the patient/entity. | Text | R | PID-3 Patient Identifier List (does not pass Variable ID or label) | CX | R | [1..1] | Only the sending system's internally assigned patient id used for these de-identified messages | |||||
DEM115 | Birth Date | Reported date of birth of patient. | Date | O | PID-7 Date/Time of Birth (does not pass Variable ID or label) | TS | O | [0..1] | ||||||
DEM113 | Patient’s sex | Patient’s current sex. | Code | O | Male Female Unknown |
Sex (MFU) | PID-8 Administrative Sex (does not pass Variable ID or label) | IS | O | [0..1] | ||||
DEM152 | Race Category | Field containing one or more codes that broadly refer to the patient’s race(s). | Code | O | Y | Native Hawaiian or Other Pacific Islander American Indian or Alaska Native Asian White Black or African American Other Race |
Race Category | PID-10 Race (does not pass Variable ID or label) | CE | O | [0..*] | |||
DEM153 | Detailed Race | A patient record may have zero, one, or multiple detailed race categories assigned. | Code | O | Y | Detailed Race | Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. To keep the race category in context with detailed races, pass the race category in the first instance of this field and the detailed race codes as repeats. If more than one race category was passed in PID-10 Race, use a second OBX Detailed Race segment instance to keep that grouping in context. | CWE | O | [0..*] | ||||
DEM155 | Ethnic Group Code | Ethnic origin or ethnicity is based on the individual’s self-identity of the patient as Hispanic or Latino; choose one value from the list. | Code | O | Hispanic Non-hispanic |
Ethnicity Group | PID-22 Ethnic Group (does not pass Variable ID or label) | CE | O | [0..1] | ||||
DEM156 | Detailed Ethnicity | If the value specified in Ethnicity is Hispanic or Latino, choose detailed ethnicity value(s) that better define the patient's Latino ethnicity; values may include Cuban, Mexican, etc.; choose one or multiple values from this list. This variable is not passed unless specified for the particular condition. | Code | O | Y | Detailed Ethnicity | Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. | CWE | [0..*] | |||||
DEM2003 | US Citizen | Is the patient a US citizen? | Boolean | O | True False |
Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. | IS | O | [0..1] | Used IS datatype to pass only T or F | ||||
DEM2004 | Nationality | What is the patients country of origin? | Code | O | Country | Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. | CWE | O | [0..1] | |||||
DEM2005 | Date of Entry into US | Date arrived in U.S. from another country. | Date | O | Observation/OBX Segment with this UID and label under the Patient Subject section header in OBR-4. | TS | O | [0..1] |
TB Case Notification variables. | ||||||||||||||
Program-Specific Surveillance Variables | Mapping Methodology | |||||||||||||
PHIN Variable ID | Label/Short Name | Description | Data Type | CDC Req/Opt | May Repeat | Coded Concepts | Value Set Name | Data Validation | Message Context | HL7 Data Type | HL7 Usage | HL7 Cardinality | Implementation Notes | |
TB098 | Investigation Submitted By | Name of the person who should be contacted if there are questions regarding the data in the report (typically the person submitting the report). | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB203 | RVCT Status | Indicate the current status of the RVCT (such as open, rejected, or closed); possible values: Approved - indicates the RVCT was reviewed by a reviewer and approved; the record appears as an alert in the worklist of a supervisor to be forwarded to the CDC and/or closed; Closed - indicates the RVCT is complete and no longer active; Deleted - deletes the record; users with the delete privilege granted by security template make this status setting to delete the RVCT record; Notified - indicates that the RVCT record was submitted to the CDC; supervisor users with the appropriate security privilege make this setting, which causes the record to be transmitted to the CDC; Opened - initial state of an RVCT record; the RVCT has been created, but not yet completed; Ready for Review - indicates the RVCT is ready for review by a reviewer; changing status to this value causes the record to appear as an alert in the worklist of a reviewer; Rejected - indicates the RVCT was reviewed by a reviewer and found to be incomplete or incorrect; the record appears as an alert in the worklist of the data entry user who owns the RVCT; Suspended - indicates that the record is temporarily inactive; used to prevent a record from being included in reports without closing and re-opening the record. | Code | R | Approved Notified Closed Deleted Opened Ready for Review |
Case Investigation Status | IF the user changes the status of the RVCT to 'Approved' THEN enable the entry of the 'Do you want to count this patient at the CDC as a verified case of TB?' question value.; IF the user changes the status of the RVCT to 'Approved' THEN enable the entry of the Approval Comments.; IF the user changes the status of the RVCT to 'Rejected' THEN enable the entry of the Rejection Comments; IF the user changes the status of the RVCT to 'Deleted' THEN enable the entry of the Rejection Comments; IF the status of an RVCT is 'Closed' THEN the status cannot be changed to 'Deleted.'; IF the RVCT has a status = 'Closed' or 'Deleted' THEN the status of the RVCT cannot be changed to 'Suspend.' |
Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB080 | Reporting Address City | City name associated with the address, zip code, and state values. | Text | O | City | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||||
TB099 | Inside City Limits | Indicate whether or not the address is within city limits; choose Unknown if it is not known for sure whether it is. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB081 | Reporting Address County | Reporting address county. | Code | O | county FIPS codes | County | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB082 | Reporting Address Zip Code | Reporting address Zip Code. | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB100 | Date Counted | If a value of Yes is specified for Do you want to count this patient at the CDC as a verified case of TB?, then enter the month and year for which the case is to be counted. | Date | R | Validate that the Count date is equal to or after Patient Date of Birth; Validate that the Count date is equal to or after Date Entered US; Validate that the Count date is equal to or after Report date; Validate that the Count date is more than 12 months after previous TB year; | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB199 | Legacy Client ID | Legacy Client ID. This field may be used to pass a patient identifier from a legacy system being converted to the new TB format. | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB200 | Legacy RVCT ID | Legacy RVCT ID. This field may be used to pass a TB Case identifier from a legacy system being converted to the new TB format. | Text | O | Observation/OBX Segment | ST | O | [0..0] | ||||||
TB202 | Estimated US Entry Date Indicator | Date the patient entered the US if the patient was not US-born or not born overseas to US parents (e.g., born on a military base); outlying US areas (e.g., Puerto Rico, Guam, Virgin Islands) are not considered part of the United States and they should be listed as separate countries. | Boolean | O | Observation/OBX Segment with this UID and label | IS | O | [0..1] | ||||||
TB101 | Status at Diagnosis of TB | Status of the patient at the time tuberculosis was diagnosed (alive, dead, or unknown). | Code | O | Alive Dead Unknown |
General Condition Status | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB102 | Previous Diagnosis of TB | Indicates whether the patient had a previous diagnosis of tuberculosis; choose Yes if the patient had a verified case of the disease in the past, had been discharged (completed therapy), or was lost to supervision for more than 12 consecutive months, and has the disease again. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB103 | Year of Previous Diagnosis | If a value of Yes was specified for Previous Diagnosis of TB, indicate the year in which the previous episode was diagnosed (use the format YYYY); if there were multiple previous episodes, then this is the year for the last such episode. | Date | O | Validate that the Patient Date of Birth is equal to or before Previous TB diagnosis year | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB104 | More than One Previous Episode | More than one previous episode. | Boolean | O | Observation/OBX Segment with this UID and label | IS | O | [0..1] | ||||||
TB105 | Major Site of Disease | Major site of disease; choose one item from the list. | Code | O | Lymphatic Other Lymphatic Unknown Eye and ear appendages Miliary Site not Stated Fetus and embryo Liver structure Bone and joint Epiglottis and larynx Jejunum and ileum Middle ear AND mastoid cells Placenta, umbilical cord and implantation site Paranasal sinus part Meninges structure Brain structure Bone marrow structure Pancreatic structure Extrahepatic duct structure Cardiac valve structure Entire duodenum Entire mouth region Urogenital structure Tongue structure Adrenal structure Nervous system structure Spinal cord structure Intrathoracic lymphatic structure Gallbladder structure Thyroid and/or parathyroid structures Tonsil and adenoid structure Pleural structure Esophageal structure Rectum structure All teeth, gums and supporting structures Salivary gland structure Lung structure Skin structure Tracheal structure Nasal structure Lip structure Anal structure Pharyngeal structure Pituitary structure Blood vessel structure Appendix structure Stomach structure Nasopharyngeal structure Colon structure Subcutaneous tissue structure Breast structure Pericardial structure Splenic structure Heart structure Cervical lymph node structure Peritoneal cavity structure Blood Thymus gland structure |
Major Site of Disease (TB) | Validate that the Major Site has a value then must not be the same value as additional site; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Sputum Culture; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Micro Exam Sites 1 and 2 | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB106 | Additional Site of Disease | Additional sites affected; do not make choices in this list if Miliary was specified in Major Site of Disease. | Code | O | Y | Lymphatic Other Lymphatic Unknown Eye and ear appendages Miliary Fetus and embryo Liver structure Bone and joint, CS Epiglottis and larynx, CS Jejunum and ileum, CS Middle ear AND mastoid cells Placenta, umbilical cord and implantation site Paranasal sinus part Meninges structure Brain structure Bone marrow structure Pancreatic structure Extrahepatic duct structure Cardiac valve structure Entire duodenum Entire mouth region Urogenital structure Tongue structure Adrenal structure Nervous system structure Spinal cord structure Intrathoracic lymphatic structure Gallbladder structure Thyroid and/or parathyroid structures Tonsil and adenoid structure Pleural structure Esophageal structure Rectum structure All teeth, gums and supporting structures Salivary gland structure Lung structure Skin structure Tracheal structure Nasal structure Lip structure Anal structure Pharyngeal structure Pituitary structure Blood vessel structure Appendix structure Stomach structure Nasopharyngeal structure Colon structure Subcutaneous tissue structure Breast structure Pericardial structure Splenic structure Heart structure Cervical lymph node structure Peritoneal cavity structure Blood Thymus gland structure |
Additional Site of Disease (TB) | Validate that the Major Site has a value then must not be the same value as additional site; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Sputum Culture; If Major Site/Additional Site not equal Pulmonary, Pleural, Lymphatic Intrathoracic, or Miliary - make sure to remove Positive from valid list of values for Micro Exam Sites 1 and 2 | Observation/OBX Segment with this UID and label | CWE | O | [0..*] | ||
TB107 | More than One Additional Site | More than one additional site indicator. This is a derived field: If Additional Site of Disease has a value, set = TRUE. | Boolean | O | Observation/OBX Segment with this UID and label | IS | O | [0..1] | ||||||
TB108 | Sputum Smear | Results of a sputum smear; choose Positive if any one examination is positive for acid-fast organisms; choose Negative if the results of all or the only examination were negative; choose Not Done if a sputum smear is known to have not been done; choose Unknown if it is not known whether a sputum smear was performed (or if the results are not known for reasons other than the results are pending). | Code | O | Positive Negative Not Done Unknown |
Positive Negative Unknown Not Done | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB109 | Sputum Culture | Results of a sputum culture; choose Positive if any one examination is positive for M. tuberculosis complex (if the culture grows organisms other than M. tuberculosis, M. bovis, or M. africanum, then choose Negative); choose Negative if the results were negative for M. tuberculosis complex; choose Not Done if a sputum culture is known to have not been done; choose Unknown if it is not known whether a sputum culture was performed (or if the results are not known for reasons other than the results are pending). | Code | O | Positive Negative Not Done Unknown |
Positive Negative Unknown Not Done | Validate that if Sputum Culture OR CULTURE equals 'Positive' then enable Initial Susceptibility test; IF (Q18) SPUTUM CULTURE equals "Positive" then enable (Q35A) SPUTUM CULTURE CONVERSION.; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB110 | Microscopic Exam of Tissue and Other Body Fluids | Results of a microscopic exam (non-sputum); choose Positive if any tissue or fluid other than sputum was positive for acid-fast organisms; choose Negative if all microscopic exams were negative for acid-fast organisms; choose Not Done if exams were known to have not been performed; choose Unknown if it is not known whether microscopic exams were performed (or if the results are not known for reasons other than the results are pending). | Code | O | Positive Negative Not Done Unknown |
Positive Negative Unknown Not Done | If Microscopic Exam equals Positive, THEN enable Microscopic First Site; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB111 | Microscopic Exam Site 1 | If a value of Positive is specified for Microscopic Exam of Tissue and Other Body Fluids, choose the appropriate site; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease and additional site(s) of the disease. | Code | O | Eye and ear appendages Skeletal system (bones of head, rib cage, and vertebral column) Meninges, dural sinus, choroid plexus Skeletal system (bones of shoulder, girdle, pelvis, and extremities Other Soft tissue (muscles of head, neck, mouth and upper extremity Soft tissue (muscles of trunk, perineum, and lower extremity Multiple Sites Omentum and peritoneum CSF (cerebrospinal fluid) Fallopian tube, broad ligament, parametrium, and paraovarian region Ovary Female genital fluids Placenta, umbilical cord, and implantation site Pituitary gland Adrenal gland Ear and mastoid cells Thymus Pus Brain Spinal cord Cranial, spinal and peripheral nerve Lung Myometrium Thyroid or parathyroid gland(s) Cardiac valve Liver Bronchus Bronchiole Pleura Upper respiratory fluids Bronchial fluid Pleural fluid Epiglottis and larynx Heart Nasopharynx Pericardial fluid Blood vessel Mouth Lip Tongue Tooth, gum and supporting structures of the tooth Salivary gland Pericardium Lymph node Kidney Endometrium Skin and skin appendages Subcutaneous tissue Breast Milk Bone marrow Trachea Blood Soft tissue (not otherwise specified) Bone (not otherwise specified) Tendon and tendon sheath Ligament and fascia Joints (synovial tissue) Synovial fluid Nose Accessory sinus Spleen Testis Gastric aspirate Gastrointestinal contents (feces) Peritoneal fluid Renal pelvis Ureter Urinary bladder Urethra Anus Prostate and seminal vesicle Urine Epididymis, vas deferens, spermatic cord and scrotum Male genital fluids Vulva, labia, clitoris, and Bartholin's gland Cervix Uterus Gallbladder Vagina Penis Rectum Small intestine - duodenum Small intestine - jejunum & ileum Esophagus Tonsils and adenoids Appendix Stomach Saliva Pharynx, oropharynx, and hypopharynx Pancreas Extrahepatic bile duct Colon Bile and pancreatic fluid Fetus and embryo |
Microscopic Exam Culture Site (TB) | Validate that the Microscopic first site has a value then must not be the same value as Microscopic second site; If Microscopic First Site has a value, THEN enable Microscopic Second Site | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB112 | Microscopic Exam Site 2 | If a value of Positive is specified for Microscopic Exam of Tissue and Other Body Fluids, choose the appropriate site if a second site is applicable; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease and additional site(s) of the disease. | Code | O | <see TB111> | Microscopic Exam Culture Site (TB) | Validate that the Microscopic first site has a value then must not be the same value as Microscopic second site; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB113 | Culture of Tissue and Other Body Fluids | Results of a culture of tissue or bodily fluid (non-sputum); choose Positive if any tissue or fluid other than sputum was positive for M. tuberculosis complex; choose Negative if all cultures were negative; choose Not Done if the cultures were known to have not been performed; choose Unknown if it is not known whether the cultures were performed (or if the results are not known for reasons other than the results are pending). | Code | O | Positive Negative Not Done Unknown |
Positive Negative Unknown Not Done | Validate that if Other Culture equals 'Positive' then enable Other culture first site; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB114 | Culture Site 1 | If a value of Positive is specified for Culture of Tissue and Other Body Fluids, choose the appropriate site; the values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease, and additional site(s) of the disease. | Code | O | <see TB111> | Microscopic Exam Culture Site (TB) | Validate that the Other Culture first site has a value then must not be the same value as Other culture second site; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB115 | Culture Site 2 | If a value of Positive is specified for Culture of Tissue and Other Body Fluids, choose the appropriate site if a second site is applicable. The values that appear in this list may vary from one case to the next as they are determined by values entered earlier for the patient's sex (in the patient record), major site of the disease, and additional site(s) of the disease. | Code | O | <see TB111> | Microscopic Exam Culture Site (TB) | Validate that the Other Culture first site has a value then must not be the same value as Other culture second site | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB116 | Chest X-ray Results | Results of a chest x-ray; choose Abnormal if the results indicate; choose Not Done if the x-rays were known to have not been done; choose Unknown if it is not known whether the x-rays were done (or if the results are unknown). | Code | O | Abnormal Normal Unknown Not done |
Chest XRay Result | Validate that if X-Ray equals 'Abnormal' then enable X-Ray abnormality, X-Ray status; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB117 | Abnormal Chest X-ray Cavitary Status | If a value of Abnormal is specified in Chest X-Ray, then indicate whether any of the x-rays done at any time during this episode of tuberculosis showed a cavity or cavities, was noncavitary consistent with tuberculosis, or was noncavitary inconsistent with tuberculosis. | Code | O | Cavity Noncavitary consistent w TB Noncavitary not consistent w TB Unknown |
Abnormal Chest XRay Finding (TB) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB118 | Abnormal Chest X-ray Condition Status | If a value of Abnormal is specified in Chest X-Ray, then indicate if a series of x-rays show the disease to be stable, worsening, or improving (do not update this information through the course of the patient's follow-up; use the indication at the time of the report). | Code | O | Improving Stable Unknown Worsening |
Abnormal Chest X-ray Condition Status | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB119 | Skin Test at Diagnosis | Results of a skin test (Mantoux - tuberculin, PPD, STU); choose Positive if the patient is probably infected with M. tuberculosis; choose Negative if the skin test did not meet the current criteria for a positive test; choose Not Done if the skin test was known to have not been performed; choose Unknown if it is not known whether the skin test was performed (or if the results are not known). | Code | O | Positive Negative Not Done Unknown |
Positive Negative Unknown Not Done | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB120 | Millimeters of Induration | If a value of Positive is specified in Skin Test at Diagnosis, indicate the millimeters of induration (if the result only indicates that the result was positive but does not specify induration, specify 99 here); | Numeric | O | Observation/OBX Segment with this UID and label | SN | O | [0..1] | ||||||
TB121 | Was Patient Anergic | If a value of Negative is specified in Skin Test at Diagnosis, indicate whether or not the patient was known to be anergic (i.e., the patient shows no immune response due to being immunocompromised) | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB122 | HIV Status | Indicate the patient's HIV status; choose Indeterminate if the patient has had a documented indeterminate HIV antibody test within the past year before the tuberculosis diagnosis; choose Negative if the patient has had a documented negative HIV antibody test within the past year before the tuberculosis diagnosis; choose Not Offered if the patient was not offered an HIV test at the time of the tuberculosis diagnostic evaluation; choose Positive if the patient was tested for HIV and the laboratory result is interpreted as positive; choose Refused if the patient was offered an HIV test at the time of the tuberculosis diagnostic evaluation, but declined to be tested; choose Test Done/Results Unknown if the patient has been tested and the results are not known; choose Unknown if it is not known if the patient has had an HIV antibody test or was offered a test. | Code | O | Unknown Test Done, Results Unknown Positive Procedure refused Negative Not offered Indeterminate |
HIV Status | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB123 | HIV Based On | If a value of Positive is specified for HIV Status, indicate the basis for the value entered (patient history, medical documentation, or unknown). | Code | O | Chart evaluation, medical records perspective History taking Unknown |
HIV Diagnosis Based On | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB124 | CDC AIDS Patient Number | If a value of Positive is specified for HIV Status, enter the CDC AIDS patient number (if AIDS is reported prior to 1993). | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB125 | State AIDS Patient Number | If a value of Positive is specified for HIV Status, enter the state HIV/AIDS patient number (if AIDS is reported in 1993 or later). | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB126 | City County AIDS Patient Number | If a value of Positive is specified for HIV Status, enter the city or county HIV/AIDS patient number (if AIDS is reported in 1993 or later). | Text | O | Observation/OBX Segment with this UID and label | ST | O | [0..1] | ||||||
TB127 | Homeless Within Past Year | Indicate whether the patient was homeless at any time during the 12 months preceding the tuberculosis diagnostic evaluation. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB128 | Resident of Correctional Facility at Time of Diagnosis | Indicate whether the patient was a resident of a correctional facility at the time the tuberculosis diagnostic evaluation was performed. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB129 | Type of Correctional Facility | If a value of Yes is specified for Resident of Correctional Facility at Time of Diagnosis, indicate the type of correctional facility. | Code | O | Unknown State Prison Juvenile Correctional Facility Federal Prison Local Jail Other Correctional Facility |
Type of Correctional Facility | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB130 | Resident of Long Term Care Facility at Time of Diagnosis | Indicate whether the patient was a resident of a long term care facility at the time the tuberculosis diagnostic evaluation was performed. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB131 | Type of Long Term Care Facility | If a value of Yes is specified for Resident of Long Term Care Facility at time of Diagnosis, indicate the type of long term care facility | Code | O | Alcohol or Drug Treatment Facility Hospital-Based Facility Residential Facility Long term care hospital Nursing home Psychiatric hospital |
Type of Long Term Care Facility | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB132 | Isoniazid therapy | Isoniazid therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB133 | Rifampin therapy | Rifampin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB134 | Pyrazinamide therapy | Pyrazinamide therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB135 | Ethambutol therapy | Ethambutol therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB136 | Streptomycin therapy | Streptomycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB137 | Ethionamide therapy | Ethionamide therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB138 | Kanamycin therapy | Kanamycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB139 | Cycloserine therapy | Cycloserine therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB140 | Capreomycin therapy | Capreomycin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB141 | Para-Amino Salicylic Acid therapy | Para-Amino Salicylic Acid therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB142 | Amikacin therapy | Amikacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB143 | Rifabutin therapy | Rifabutin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB144 | Ciprofloxacin therapy | Ciprofloxacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB145 | Ofloxacin therapy | Ofloxacin therapy: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if the drug is known to not be part of the initial regimen; choose Unknown if it is not known whether the drug is part of the initial regimen; choose Yes if it is known that the drug is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB146 | Other initial regimen | Other initial regimen: Indicate the drug regimen initially prescribed for the treatment of the current case of the disease and taken for two weeks: choose No if there is no other drug known to be part of the initial regimen; choose Unknown if it is not known whether another drug is part of the initial regimen; choose Yes if it is known that an drug not already listed is part of the initial regimen. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | IF the user has selected the option to save the RVCT but has not selected an answer for each drug in the question Initial Susceptibility Test (33A) THEN the system will present a warning message to the user indicating that each drug does not have a response. | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB147 | Date Therapy Started | Date on which the patient began therapy for tuberculosis (or suspected tuberculosis). This date may be derived from: the date the patient first ingested medication (if documented in a medical record or directly observed therapy record); the date medication was first dispensed to the patient (as documented in a medical or pharmacy record); the date medication was first prescribed to patient by a health care provider (documented in a medical record or prescription given to the patient) | Date | O | Validate that the Date Therapy Started is equal to or before stop therapy date; Validate that if the Date Therapy Started has a value then the value for DOT Weeks must not be greater than the number of weeks between Date Therapy Started and Stop Therapy Date; IF Initial Drug Regimen has at least one drug with a value of "Yes" [drug selected in the initial drug regimen] then enableDate Therapy Started; | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB148 | Injecting Drug Use Within Past Year | Indicate whether the patient has injected drugs within the past year (use of a syringe for injecting drugs not prescribed by a physician); No if it is known that the patient has not injected drugs within the past 12 months; Unknown if it is not known whether or not the patient has injected drugs within the past 12 months; Yes if it is known that the patient has injected drugs within the past 12 months. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB149 | Non-Injecting Drug Use Within Past Year | Indicate whether the patient has used non-injected drugs within the past year (drugs not prescribed by a physician); No if it is known that the patient has not used non-injected drugs within the past 12 months; Unknown if it is not known whether or not the patient has used non-injected drugs within the past 12 months; Yes if it is known that the patient has used non-injected drugs within the past 12 months. | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB150 | Excess Alcohol Use Within Past Year | Indicate whether the patient engaged in excessive use of alcohol within the past year; No if it is known that the patient did not use alcohol to excess within the past 12 months; Unknown if it is not known whether the patient used alcohol to excess within the past 12 months; choose Yes if it is known that the patient used alcohol to excess within the past 12 months | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB151 | Employment Status | Patient’s Employment Status: Unknown if the employment history of the patient during the 24 months preceding the tuberculosis diagnostic evaluation is not known; Not Employed if the patient was not employed during the entire 24 months preceding the tuberculosis diagnostic evaluation; Employed if the patient was employed for some part of the 24 months preceding the tuberculosis diagnostic evaluation. | Code | O | Employed Unemployed Unknown |
Employment Status | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB152 | Occupation Risk Category | Occupation Risk Category. This is a derived field: If OCCUPATION_HEALTH_CARE_INDICATOR (FC783) = TRUE, then set to 'Health Care Worker'. If OCCUPATION_MIGRATORY_AG_INDICATOR (FC785) = TRUE, then set to 'Migratory Agricultural Worker'. If OCCUPATION_CORRECTIONAL_INDICATOR (FC784) = TRUE, then set to 'Correctional Employee'. If OCCUPATION_OTHER_INDICATOR (FC786) = TRUE, then set to 'Other Occupation'. | Code | O | Y | Health Care Worker Migratory Agricultural Worker Correctional Facility Employee Other Occupation |
Occupation Risk Category (TB) | Observation/OBX Segment with this UID and label | CWE | O | [0..*] | |||
TB153 | Count at CDC as verified | Yes if the case is to be counted as verified at CDC. | Code | R | True False |
Yes No Indicator (HL7) | If Vercount = "Yes", then the Month/Year counted and MMWR Reporting Date are required; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB154 | Case Verification | Initially, the value selected in this list is based on data entered earlier across the course of the case and the default value is the most applicable case verification result based on the data supplied; the default value may be overridden as appropriate; the values that appear in this list can vary from one case to the next as the list is dynamically composed based on the factors: culture results, smear results, major and additional sites of the disease, x-ray results, TST, IDR, reason therapy was stopped. The values for this field include: • 0 - Not a Verified Case: choose if the case is not a verified case of tuberculosis; • 1 - Positive Culture: choose if the case is a verified case, based on a positive sputum culture result; • 2 - Positive Smear/Tissue: choose if the case is a verified case, based on a positive sputum smear result and/or tissue (or fluid) exam; • 3A - Clinical Case Definition - PULM: choose if the case is a verified case, based on pulmonary conditions; • 3B - Clinical Case Definition - Extra-PULM: choose if the case is a verified case, based on extra-pulmonary conditions; • 4 - Verified by Provider Diagnosis: choose if the case is a verified case, based on healthcare provider diagnosis; • 5 - Suspect: choose if the case is not verified, but the healthcare provider suspects the case to be one of tuberculosis. | Code | R | 0 - Not a Verified Case 1 – Positive Culture 5 – Suspect 3B – Clinical Case Definition – Extra-PULM 3A – Clinical Case Definition – PULM 4 - Verified by Provider Diagnosis 2 – Positive Smear/Tissue |
Case Verification (TB) | If VERCRIT is 1, 2, 3, or 4, display the count date question; IF [Sputum Smear (17) = 'Positive' OR Microscopic Exam of Tissue and Other Body Fluids (19) = 'Positive'] AND [Sputum Culture (18) = 'Not Done' or 'Unknown' AND Culture of Tissue and Other Body Fluids (20) = 'Not Done' or Unknown] THEN Case Verification (VERCRIT) = 2 - Positive Smear/Tissue.; IF [Major Site (15) or Additional Site (16) = 'Pulmonary' and/or 'Pleural' and/or 'Lymph: Intrathoracic'] AND [Sputum Culture (18) <> 'Positive' AND Culture of Tissue and Other Body Fluids (20) <> 'Positive'] AND [Tuberculin Skin Test at Diagnosis (22) = 'Positive'] AND [Initial Drug Regimen (27) at least two of the listed medications = 'Yes'] AND [{X-Ray (21A) = 'Abnormal'} AND {X-Ray Condition (21B) = 'Cavitary' or 'Non-Cavitary Like TB'} AND {X-Ray Stability (21C) = 'Worsening' or 'Improving'}] THEN Case Verification (VERCRIT) = 3A - Clinical Case Definition - PULM.; IF [Major Site (15) or Additional Site (16) = 'Lymphatic Cervical', 'Lymphatic Other', 'Lymphatic Unknown', 'Bone and/or Joing', 'Genitourinary', 'Miliary', 'Memingeal', 'Peritoneal', 'Site Not Stated', or 'Other'] AND [Sputum Culture (18) <> 'Positive' AND Culture of Tissue and Other Body Fluids (20) <> 'Positive'] AND [Tuberculin Skin Test at Diagnosis (22) = 'Positive'] AND [Initial Drug Regimen (27) at least two of the listed medications = 'Yes'] THEN Case Verification (VERCRIT) = 3B - Clinical Case Definition - Extra-PULM.; IF Case Verification (VERCRIT) <> '1 - Positive Culture' OR '2 - Positive Smear/Tissue' OR '3A - Clinical Case Definition - PULM' OR '3B - Clinical Case Definition - Extra-PULM' THEN Case Verification (VERCRIT) = 5 - Suspect.; If Case Verification (VERCRIT) = '5 - Suspect' THEN the user may only change the Case Verification to either '4 - Verified by Provider Diagnosis' or '0 - Not TB' ; FC123: SHALL NOT allow RVCTS with automatically calculated (based on specific RVCT question values) VERCRITS = "0 - Not a Verified Case", "1-Positive Culture", "2-Positive Smear/Tissue", or "3-Clinical Case Definition" to be changed to any other VERCRIT value.; FC124: SHALL allow RVCTs with VERCRITS = "5 - Suspect" to be changed to "4 - Verified by Provider" or "0-Not TB" OR RVCTs with VERCRITS = "4 - Verified by Provider" to be changed to "5 - Suspect" or "0 - Not TB" OR RVCTs with VERCRITS = "0 - Not TB" to be changed to "5 - Suspect" or "4 - Verified by Provider". |
Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB156 | Was Drug Susceptibility Testing Done | Indicate whether a drug susceptibility test was performed; No if no drug susceptibility test was performed; Unknown whether drug susceptibility testing was performed; Yes if the patient has any isolate upon which drug susceptibility testing was performed | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB157 | Date First Isolate Collected | If a value of Yes is specified for Was Drug Susceptibility Testing Done, collection date of the first isolate on which drug susceptibility was performed. | Date | O | Validate that the Initial susceptibility test date is at least 30 days before Final susceptibility test date; Validate that the Patient Date of Birth is equal to or before Initial Susceptibility test date; Validate that the Date Entered U.S. is equal to or before initial susceptibility test date; Validate that the Previous TB Year is greater than 12 months before Initial Susceptibility test date | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB158 | Isoniazid initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Isoniazid: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB159 | Rifampin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Rifampin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB160 | Pyrazinamide initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Pyrazinamide: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB161 | Ethambutol initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ethambutol: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB162 | Streptomycin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Streptomycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB163 | Ethionamide initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed forEthionamide: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB164 | Kanamycin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Kanamycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB165 | Cycloserine initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Cycloserine: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB166 | Capreomycin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Capreomycin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB167 | Para-Amino Salicylic Acid initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Para-Amino Salicylic Acid: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB168 | Amikacin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Amikacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB169 | Rifabutin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Rifabutin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB170 | Ciprofloxacin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ciprofloxacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB171 | Ofloxacin initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for Ofloxacin: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB172 | Other initial susceptibility | Indicate the results of susceptibility testing on the first isolate for which drug susceptibility testing was performed for the other initial therapy drug: Not Done if susceptibility testing was not performed for the drug; Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug); Susceptible if (and only if) completely susceptible; Unknown if it is not known whether the test was performed or the results are unavailable. | Code | O | Resistant Susceptible |
Susceptibility Result | IF a drug is marked as Resistant in the Initial Susceptibility (34) section then the system should put a visual indicator by that drug in the Final Susceptibility (41) section | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB173 | Culture Conversion Documented | Indicate whether the sputum culture conversion was documented; No if the patient had an initially positive sputum culture and no subsequent consistently negative cultures; Unknown if the results of all follow-up cultures are unknown or if it is not known whether follow-up cultures were obtained; Yes if the patient had an initially positive sputum culture followed by one or more consistently negative cultures | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB174 | Date of Initial Positive Culture | Date the initially positive sputum culture was collected. | Date | O | Validate that the Patient Date of Birth is equal to or before First positive culture date; Validate that the Date Entered U.S. is equal to or before first positive culture date; Validate that the Previous TB Year. is greater than 12 months before First positive culture date; Validate that the First positive culture date is before First negative culture date; | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB175 | Date of First Consistently Negative Culture | Date the first consistently negative sputum culture was collected. | Date | O | Validate that the Patient Date of Birth is equal to or before First negative culture date;Validate that the Date Entered U.S. is equal to or before first negative culture date; Validate that if First Negative culture date has a date then first positive culture date has a date; Validate that the First negative culture date is more than 12 months after previous TB year; Validate that the First Negative Culture Date must be after First Positive Culture Date; | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB176 | Date Therapy Stopped | Date the patient stopped taking therapy for verified or suspected tuberculosis; this date is one of the following (in order of preference): • Date that the patient last ingested medication; • Date the medication dispensed to the patient would have run out, if the patient had taken all of the medication; • Date the medication prescribed to the patient would have run out, if the patient had taken all of the medication from the date of prescription. | Date | O | Observation/OBX Segment with this UID and label | TS | O | [0..1] | ||||||
TB177 | Reason Therapy Stopped | Primary reason that therapy was ended; specify this data when the case is closed; Completed therapy if the patient successfully completed the prescribed therapy; Moved if the patient moved to another jurisdiction before the treatment was completed; Lost if the patient cannot be located prior to the completion of treatment; Uncooperative or refused if the patient refused to complete therapy (update if the patient resumes therapy); Not TB if the completed diagnostic therapy determined that the diagnosis of tuberculosis was not substantiated; Died if the patient expired before therapy was completed; Other if therapy was discontinued for some other reason; Unknown if the reason for ending therapy is not known. | Code | O | Lost to Follow-Up/Unable to Locate Moved Uncooperative or refused |
Reason Therapy Stopped (TB) | IF Reason Therapy Stopped = "Not TB"THEN Case Verification (VERCRIT) = 0 - Not a Verified Case; | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | |||
TB178 | Type of Health Care Provider | Type of health care provider involved in the care for the patient; Health Department, Private Practice, Both Health Dept and Private/Other, or Unknown are valid concepts. | Code | O | Both Health Dept and Private/Other Private Practice Health Department |
Health Care Practice Type (TB) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | Note that this was formerly marked as "repeating" but the value set has the multiple built as a single concept, so repeating message format not necessary | |||
TB179 | Directly Observed Therapy | Choose the therapy that was directly observed by the health care provider (directly observed therapy, or DOT): No, Totally Self-Administered if no doses of medication were given under supervision; Unknown if it is not known whether any doses of medication were given under supervision; Yes, Both DOT and Self-Administered if one or more doses of medication were given under supervision and one or more were not; Yes, Totally Directly Supervised if all doses of medication were given under supervision. | Code | O | No, Totally Self-Administered Yes, Totally Directly Observed Yes, Both DOT and Self-Administered |
Directly Observed Therapy (TB) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB180 | Sites of Directly Observed Therapy | If any medication was administered under DOT conditions, select the site(s) where this occurred; may select one or multiple sites; use Ctrl+Click to select multiple sites; Both in facility and in the field if both were used (for example, the patient received medicine under DOT at a clinic and outside the clinic when the patient did not show up at the clinic); In clinic or other facility if the patient received medicine DOT at a health department or private provider facility; In the field if the patient received medicine under DOT solely outside any facility (for example, at the patient's home or workplace); Unknown if the DOT sites are not known | Code | O | Both in facility and in the field In clinic or other facility In the field |
Sites of Directly Observed Therapy (TB) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | Note that this was formerly marked as "repeating" but the value set has the multiple built as a single concept, so repeating message format not necessary | |||
TB181 | Number Weeks Directly Observed Therapy | Number of weeks of directly observed therapy (DOT); enter the total number of calendar weeks (Sunday through Saturday) that the patient received the minimum amounts of medication under DOT conditions; the number of weeks entered must be less than the number of weeks between 28. Date Therapy Started and 36. Date Therapy Stopped; If the patient was on a twice-weekly regimen: count a week only if both of the week's doses were given under DOT; If the patient was on a three-times-weekly regimen: count a week only if all three of the week's doses were given under DOT; If the patient was on a daily regimen: count a week only if five or more of the week's doses were given under DOT; If the patient was on a daily regimen: count a week only if five or more of the week's doses were given under DOT; If the patient did not receive the minimum number of doses under DOT, do not count the week. | Numeric | O | Observation/OBX Segment with this UID and label | SN | O | [0..1] | ||||||
TB182 | Follow-Up Susceptibility Testing | Indicate whether final drug susceptibility was performed; No if no final drug susceptibility testing was performed; Yes if drug susceptibility testing was performed on an isolate that was collected ³30 days after the isolate for which the initial drug susceptibility testing was done; Unknown if it is not known whether follow-up drug susceptibility testing was done | Code | O | Yes No Unknown |
Yes No Unknown (YNU) | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB183 | Follow-Up Susceptibility Testing Date | If a value of Yes is specified for Was Follow-up Susceptibility Testing Done, indicate the date on which this testing was done | Date | O | Validate that the Patient Date of Birth is equal to or before Final Susceptibility Test date; Validate that the Date Entered U.S. is equal to or before Final Susceptibility test date | Observation/OBX Segment with this UID and label | TS | O | [0..1] | |||||
TB184 | Isoniazid final susceptibility | If follow-up susceptibility testing was done, results of the testing for Isoniazid: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB185 | Rifampin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Rifampin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB186 | Pyrazinamide final susceptibility | If follow-up susceptibility testing was done, results of the testing for Pyrazinamide: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB187 | Ethambutol final susceptibility | If follow-up susceptibility testing was done, results of the testing for Ethambutol: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB188 | Streptomycin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Streptomycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB189 | Ethionamide final susceptibility | If follow-up susceptibility testing was done, results of the testing for Ethionamide: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB190 | Kanamycin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Kanamycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB191 | Cycloserine final susceptibility | If follow-up susceptibility testing was done, results of the testing for Cycloserine: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB192 | Capreomycin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Capreomycin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB193 | Para-Amino Salicylic Acid final susceptibility | If follow-up susceptibility testing was done, results of the testing for Para-Amino Salicylic Acid: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB194 | Amikacin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Amikacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB195 | Rifabutin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Rifabutin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB196 | Ciprofloxacin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Ciprofloxacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB197 | Ofloxacin final susceptibility | If follow-up susceptibility testing was done, results of the testing for Ofloxacin: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] | ||||
TB198 | Other final susceptibility | If follow-up susceptibility testing was done, results of the testing for Other Drugs: Resistant if there was any degree of resistance (even partial or resistance at a low concentration of the drug; Susceptible if completely susceptible; Not Done if susceptibility testing was not performed for the drug; Unknown if it is not known whether drug susceptibility testing was performed for the drug. | Code | O | Resistant Susceptible |
Susceptibility Result | Observation/OBX Segment with this UID and label | CWE | O | [0..1] |
These variables are not negotiable. Default values are provided for HL7 structural elements that are required but not part of the surveillance data requested. | ||||||||||||||
Notification Variables | Mapping Methodology | |||||||||||||
PHIN Variable ID | Label/Short Name | Description | Data Type | CDC Req/Opt | May Repeat | Coded Concepts | Value Set Name | Data Validation | Message Context | HL7 Data Type | HL7 Usage | HL7 Cardinality | Implementation Notes | |
NOT108 | Notification ID | The unique identifier for the notification record. | String | R | MSH-10-Message Control ID. No UID or label is passed in the message. | ST | R | [1..1] | HL7 recommended size increased to 50 | |||||
DEM197 | Local patient ID | The local ID of the patient/entity. | String | R | PID-3.1 Patient Identifier List – ID Number PID-3.4 Assigning Authority format <localID&OID&ISO> Does not pass Variable ID or label. |
CX | R | [1..1] | Only the sending system's internally assigned patient id used for these de-identified messages | |||||
DEM100 | Patient name type | Name is not requested by the program, but the Patient Name field is required to be populated for the HL7 message to be valid. Have adopted the HL7 convention for processing a field where the name has been removed for de-identification purposes. | Coded | R | Pseudonomized name | Name Type (HL7) | PID-5.7 Patient Name Type - second instance (does not pass Variable ID or label). HL7 reserves the first instance of the name for Legal Name. | XPN | R | [1..2] | Literal value: |~^^^^^^S| | |||
INV168 | Local record ID | Sending system-assigned local ID of the case investigation with which the subject is associated.(This is the RVCT ID for TB) | Text | R | OBR-3-Filler Order Number where OBR-3.1 is the internally assigned case/investigation ID, OBR-3.3 is the OID for sending application as assigning authority, and OBR-3.4 is the literal value 'ISO'. The UID and label are not passed in the message. | EI | R | [1..1] | <same value in each OBR instance> | |||||
NOT099 | Subject Type | Type of subject for the notification. | Coded | R | Notification Section Header | OBR|1|: Maps to the HL7 attribute OBR-4-Universal Service ID. No UID or label is passed in the message. | CE | R | [1..1] | Literal Value: 'PERSBJ^Person Subject^2.16.840.1.114222.4.5.274' | ||||
NOT101 | Notification Type | Type of notification. Main notification types are "Individual Case", "Environmental", "Summary", and "Laboratory Report". | Coded | R | Notification Section Header | OBR|2|: Maps to the HL7 attribute OBR-4-Universal Service ID. No UID or label is passed in the message. | CE | R | [1..1] | Literal Value: 'NOTF^Case Notification^2.16.840.1.114222.4.5.274' | ||||
NOT103 | Date First Submitted | Date the notification was first sent to CDC. This value does not change after the original notification. | Date/time | R | Maps to the HL7 attribute OBR-7-Observation Date/time. No UID or label is passed in the message. | TS | R | [1..1] | <same value in each OBR instance> | |||||
NOT106 | Date of Report | Date/time this version of the notification was sent. It will be the same value as NOT103 for the original notification. For updates, this is the update/send date/time. | Date/time | R | Maps to the HL7 attribute OBR-22-Result Report/Status Chg Date/time. No UID or label is passed in the message. | TS | R | [1..1] | <same value in each OBR instance> | |||||
INV169 | Condition Code | Condition or event that constitutes the reason the notification is being sent. | Coded | R | Nationally Notifiable Infectious Disease (NNID) reportable to the Nationally Notifiable Disease Surveillance System (NNDSS) | Maps to HL7 attribute OBR-31-Reason for Study. The UID and label are not passed in the message. | CE | R | [1..1] | Default value in each OBR instance: '10220^Tuberculosis^2.16.840.1.1142224.5.78' |
File Type | application/vnd.ms-excel |
Author | zvx6 |
Last Modified By | wsb2 |
File Modified | 2007-09-11 |
File Created | 2006-11-07 |